12 clinical trials for cardiac vesicle repair launching in 2026
As 2026 commences, cardiovascular medicine is witnessing a historic pivot toward cell-free regenerative strategies for myocardial infarction recovery. Recent directives from global health organizations are prioritizing the development of exosome-enriched hydrogels that can be applied directly to damaged heart tissue during minimally invasive procedures. This technological surge follows landmark...
0 Reacties 0 aandelen 589 Views 0 voorbeeld